Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-135994
Filing Date
2025-06-05
Accepted
2025-06-05 17:21:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d15942ddefa14a.htm DEFA14A 24218
2 GRAPHIC g15942g0605012237692.jpg GRAPHIC 12217
  Complete submission text file 0001193125-25-135994.txt   42230
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 251028204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)